Utidelone monotherapy suggesting clinical efficacy in heavily pretreated platinum-resistant high-grade serous ovarian cancer: a case report
Abstract Background Platinum-resistant ovarian cancer (OC) presents a significant therapeutic challenge with limited effective salvage options and dismal survival outcomes. Utidelone (UTD1), a novel synthetic epothilone B analogue that circumvents P-glycoprotein-mediated drug efflux, demonstrates pr...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SpringerOpen
2026-04-01
|
| Серія: | Bulletin of the National Research Centre |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s42269-026-01433-8 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|